The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions
about
Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factorsA novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteersReal-world evaluation of compliance and preference in Alzheimer's disease treatment.A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patch.Real-world evaluation of compliance and preference in Alzheimer's disease treatment: an observational study in Taiwan.Utility of Göttingen minipigs for Prediction of Human Pharmacokinetic Profiles After Dermal Drug Application.Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease.Improving medication adherence among community-dwelling seniors with cognitive impairment: a systematic review of interventions.Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.Formulations: friendly, fast, forgiving and flexible.Transdermal patches: how common are application site reactions and how severe are they?The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
P2860
Q26997299-B8A0FA38-FD69-4CA5-A397-D8AB89D3FA61Q35807939-355102FF-9C56-4EA6-9F56-DAA52EC3757DQ36264977-CEA21D1E-488D-4A38-9D6C-D7FFB6129DB2Q36372148-BF19B6A1-B4E6-414B-8E76-1BA6CA5E2A06Q36766861-7DD766EE-EAA6-4FD3-8B45-BF71B1E86A4BQ38614712-5318DDC3-9513-4181-B272-65578860C3DDQ38906350-797B1802-9449-4C9C-A505-3F4F37BEEB42Q39337320-FBA1781F-9598-4BDE-8E9B-5ADC98C6DFC1Q51491144-2560F771-8129-4A7C-AC98-FE7868316F7CQ53350801-1A7AEB04-F698-479E-A2D0-4498FD269029Q56790653-763E5442-9C28-4690-8B85-3A504435DCA6Q57177786-8442317D-9453-4001-9DBC-1A891F1DFC41
P2860
The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
The transdermal formulation of ...... nder daily practice conditions
@ast
The transdermal formulation of ...... nder daily practice conditions
@en
The transdermal formulation of ...... nder daily practice conditions
@nl
type
label
The transdermal formulation of ...... nder daily practice conditions
@ast
The transdermal formulation of ...... nder daily practice conditions
@en
The transdermal formulation of ...... nder daily practice conditions
@nl
prefLabel
The transdermal formulation of ...... nder daily practice conditions
@ast
The transdermal formulation of ...... nder daily practice conditions
@en
The transdermal formulation of ...... nder daily practice conditions
@nl
P2093
P2860
P356
P1476
The transdermal formulation of ...... nder daily practice conditions
@en
P2093
P2860
P304
P356
10.1111/IJCP.12374
P577
2014-03-03T00:00:00Z